TACTILE SYSTEMS TECHNOLOGY I (TCMD) Stock Price, Quote, News and Overview
NASDAQ:TCMD - Nasdaq - US87357P1003 - Common Stock - Currency: USD
TCMD Quote, Performance and Key Statistics
14.52
-0.1 (-0.68%)
The current stock price of TCMD is 14.52 USD. In the past month the price decreased by -19.29%. In the past year, price decreased by -5.41%.
TCMD Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 29.11 | 235.82B | ||
| ISRG | INTUITIVE SURGICAL INC | 79.25 | 207.19B | ||
| BSX | BOSTON SCIENTIFIC CORP | 40.46 | 149.68B | ||
| SYK | STRYKER CORP | 32.14 | 149.34B | ||
| MDT | MEDTRONIC PLC | 16.96 | 116.15B | ||
| BDX | BECTON DICKINSON AND CO | 16.36 | 65.35B | ||
| EW | EDWARDS LIFESCIENCES CORP | 27.47 | 42.44B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 20.2 | 41.44B | ||
| IDXX | IDEXX LABORATORIES INC | 40.69 | 37.49B | ||
| DXCM | DEXCOM INC | 54.49 | 35.12B | ||
| RMD | RESMED INC | 26.54 | 34.46B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 18.38 | 25.23B |
Related stock screener links
About TCMD
Company Profile
Tactile Systems Technology, Inc. engages in developing and providing medical devices for the treatment of underserved chronic diseases. The company is headquartered in Minneapolis, Minnesota and currently employs 992 full-time employees. The company went IPO on 2016-07-28. The firm's areas of therapeutic focus are vascular disease, oncology and providing airway clearance therapy for those suffering from chronic respiratory conditions. The company is developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency and chronic pulmonary disease. The company markets Flexitouch Plus and Entre Plus systems as at-home therapies for the treatment of lymphedema and chronic venous insufficiency. The firm markets AffloVest as an at-home therapy intended to promote airway clearance. Its Flexitouch Plus system is a fully automated, programmable, advanced pneumatic compression device. The firm's Entre system is a basic pneumatic compression device. Kylee, its free mobile application, helps patients learn about lymphedema.
Company Info
TACTILE SYSTEMS TECHNOLOGY I
1331 Tyler St NE Ste 200
Minneapolis MINNESOTA 55416 US
CEO: Daniel L. Reuvers
Employees: 992
Company Website: https://www.tactilemedical.com/
Investor Relations: http://investors.tactilemedical.com/
Phone: 18664353948
TACTILE SYSTEMS TECHNOLOGY I / TCMD FAQ
What is the stock price of TACTILE SYSTEMS TECHNOLOGY I today?
The current stock price of TCMD is 14.52 USD. The price decreased by -0.68% in the last trading session.
What is the ticker symbol for TACTILE SYSTEMS TECHNOLOGY I stock?
The exchange symbol of TACTILE SYSTEMS TECHNOLOGY I is TCMD and it is listed on the Nasdaq exchange.
On which exchange is TCMD stock listed?
TCMD stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for TACTILE SYSTEMS TECHNOLOGY I stock?
11 analysts have analysed TCMD and the average price target is 21.42 USD. This implies a price increase of 47.52% is expected in the next year compared to the current price of 14.52. Check the TACTILE SYSTEMS TECHNOLOGY I stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is TACTILE SYSTEMS TECHNOLOGY I worth?
TACTILE SYSTEMS TECHNOLOGY I (TCMD) has a market capitalization of 348.48M USD. This makes TCMD a Small Cap stock.
How many employees does TACTILE SYSTEMS TECHNOLOGY I have?
TACTILE SYSTEMS TECHNOLOGY I (TCMD) currently has 992 employees.
What are the support and resistance levels for TACTILE SYSTEMS TECHNOLOGY I (TCMD) stock?
TACTILE SYSTEMS TECHNOLOGY I (TCMD) has a support level at 14.51 and a resistance level at 17.67. Check the full technical report for a detailed analysis of TCMD support and resistance levels.
Is TACTILE SYSTEMS TECHNOLOGY I (TCMD) expected to grow?
The Revenue of TACTILE SYSTEMS TECHNOLOGY I (TCMD) is expected to grow by 9.86% in the next year. Check the estimates tab for more information on the TCMD EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy TACTILE SYSTEMS TECHNOLOGY I (TCMD) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of TCMD, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of TCMD, evaluating the profitability, health, valuation and growth aspects
- TACTILE SYSTEMS TECHNOLOGY I (TCMD) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- TACTILE SYSTEMS TECHNOLOGY I (TCMD) Sales and EPS estimates to see what analysts future expectations are.
- TACTILE SYSTEMS TECHNOLOGY I (TCMD) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- TACTILE SYSTEMS TECHNOLOGY I (TCMD) Insider and Institutional Ownership to learn about the owners and their transactions.
- TACTILE SYSTEMS TECHNOLOGY I (TCMD) Stock Chart to make your own analysis
- TACTILE SYSTEMS TECHNOLOGY I (TCMD) Latest news and press-releases to stay up to date.
Does TACTILE SYSTEMS TECHNOLOGY I (TCMD) stock pay dividends?
TCMD does not pay a dividend.
When does TACTILE SYSTEMS TECHNOLOGY I (TCMD) report earnings?
TACTILE SYSTEMS TECHNOLOGY I (TCMD) will report earnings on 2025-05-05, before the market open.
What is the Price/Earnings (PE) ratio of TACTILE SYSTEMS TECHNOLOGY I (TCMD)?
The PE ratio for TACTILE SYSTEMS TECHNOLOGY I (TCMD) is 20.45. This is based on the reported non-GAAP earnings per share of 0.71 and the current share price of 14.52 USD. Check the full fundamental report for a full analysis of the valuation metrics for TCMD.
What is the Short Interest ratio of TACTILE SYSTEMS TECHNOLOGY I (TCMD) stock?
The outstanding short interest for TACTILE SYSTEMS TECHNOLOGY I (TCMD) is 6.08% of its float. Check the ownership tab for more information on the TCMD short interest.
TCMD Technical Analysis
TCMD Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to TCMD. TCMD is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average.
TCMD Financial Highlights
Over the last trailing twelve months TCMD reported a non-GAAP Earnings per Share(EPS) of 0.71. The EPS decreased by -40.83% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 5.79% | ||
| ROA | 5.69% | ||
| ROE | 7.83% | ||
| Debt/Equity | 0.11 |
TCMD Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 80% to TCMD. The Buy consensus is the average rating of analysts ratings from 11 analysts.
For the next year, analysts expect an EPS growth of 17.31% and a revenue growth 9.86% for TCMD